Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

In my "well winded" thought/opinion post, I told you what I'm attempting to do as it relates to an exit strategy. I would have stuck to exiting after the Romania COVID study but for it's crazy crash and burn. But more importantly, it wasn't a true clinical trial. We have thus far been rooting for something that statistically was never going to happen. Without stat sig it's just wasting time before a real clinical trial. As I've said here more than once, look at the drug re-purposing strategy/timeline chart.



Where it shows an entry at Phase 2 it clearly shows pre-clinical work is done beforehand. The chart is misleading at best as it relates to the actual studies being conducted thus far. Even the Romania COVID study was said to be a Phase 2b/3 clinical trial, but at the last minute we were told it wasn't powered for stat sig. That's a bait and switch. Which is why management will never show us the letter they received back from the FDA about a Phase 3 clinical trial. How or why would you run a Phase 3 with zero stat sig? It's just crazy talk by the CEO. So now I'm here until a real world clinical trial. It's the reason I had a lot of shares split in half and to date diluted 6 fold. The only thing is by the time we get final data from a Chronic Cough trial, the company should have data from the Phase 1 DMT and started a Phase 2 (Q1 2022). Will that Phase 2 be just a study or powered for stat sig? How long will that trial take to get to data? Who knows?! If a worthwhile "inflection point" ever comes along before a real data readout I'm likely going to exit for good. That number will be based on market cap and whether I think there's room for better valuation leading up to the CC final readout. Surely, I won't be around for the Cancer piece. That seems like a very far off endeavor at this point in time. Especially if it starts at Phase 1.

My thoughts.

My opinions.

Have @ it

M$